TGA: Updated warnings about persistent sexual dysfunction for antidepressants

The Australian regulator has added warnings about persistent sexual dysfunction for all SSRIs and SNRIs. The updated warning encourages health professionals to be alert to the issue and to report cases they associate antidepressant use with sexual dysfunction. Reporting adverse side effects can lead to increased warnings and labeling, which are essential for raising interest in PSSD.

Every PSSD patient is highly encouraged to take the time to fill out an adverse reaction report, which you can start by clicking here.